Global Ulcerative Colitis Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Ulcerative Colitis Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Disease Type (Mild UC, Moderate UC, and Severe UC), Molecule Type (Biologics, and Small Molecules), Route of Administration (Oral, and Injectables), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Ulcerative Colitis Market was valued at USD 6,998.5 million in 2023 and is expected to reach USD 11,582.6 million by 2031 while growing at a CAGR of 6.5% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global ulcerative colitis market growth. Ulcerative colitis, an inflammatory bowel disease (IBD), leads to inflammation and ulcers (sores) within the digestive tract. This condition primarily affects the innermost lining of the large intestine, known as the colon, as well as the rectum. Symptoms typically develop gradually over time rather than abruptly in most individuals.
Continual progress in treatment modalities, encompassing biologic therapies, immunomodulators, and targeted therapies, coupled with the increasing prevalence of ulcerative colitis and heightened awareness and diagnosis, propels market expansion. However, the market's growth is impeded by high treatment costs and adverse treatment effects.
Furthermore, the global ulcerative colitis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Disease Type Analysis
The Global Ulcerative Colitis Market is segmented among Mild UC, Moderate UC, and Severe UC, based on Disease Type. In 2023, Mild UC accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Molecule Type Analysis
The Global Ulcerative Colitis Market is segmented among Biologics, and Small Molecules, based on Molecule Type. In 2023, Small Molecules accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Ulcerative Colitis Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Ajinomoto Co. Inc, AstraZeneca Plc, Abbott Laboratories, Eli-Lily, Merck, Index Pharmaceuticals Holdings AB, GlaxoSmithKline Plc, Pfizer Inc, Sanofi SA, and Johnson & Johnson.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Ulcerative Colitis Market Dynamics
Drivers
Restraints
Opportunity
4. Global Ulcerative Colitis Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Ulcerative Colitis Market Segmentation, By Disease Type
Global Ulcerative Colitis Market Share Analysis, By Disease Type
Global Ulcerative Colitis Market Growth Analysis, By Disease Type
Global Ulcerative Colitis Market Trends, By Disease Type
o Mild UC
o Moderate UC
o Severe UC
6. Global Ulcerative Colitis Market Segmentation, By Molecule Type
Global Ulcerative Colitis Market Share Analysis, By Molecule Type
Global Ulcerative Colitis Market Growth Analysis, By Molecule Type
Global Ulcerative Colitis Market Trends, By Molecule Type
o Biologics
o Small Molecules
7. Global Ulcerative Colitis Market Segmentation, By Route of Administration
Global Ulcerative Colitis Market Share Analysis, By Route of Administration
Global Ulcerative Colitis Market Growth Analysis, By Route of Administration
Global Ulcerative Colitis Market Trends, By Route of Administration
o Oral
o Injectables
8. Global Ulcerative Colitis Market Segmentation, By Region
Global Ulcerative Colitis Market Share Analysis, By Region
Global Ulcerative Colitis Market Growth Analysis, By Region
Global Ulcerative Colitis Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Ajinomoto Co. Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
AstraZeneca Plc
Abbott Laboratories
Eli-Lily
Merck
Index Pharmaceuticals Holdings AB
GlaxoSmithKline Plc
Pfizer Inc
Sanofi SA
Johnson & Johnson
*Similar analysis will be provided for each company listed above.